These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
191 related articles for article (PubMed ID: 22212957)
1. Phosphorylation of serine 21 modulates the proliferation inhibitory more than the differentiation inducing effects of C/EBPα in K562 cells. Fragliasso V; Chiodo Y; Ferrari-Amorotti G; Soliera AR; Manzotti G; Cattelani S; Candini O; Grisendi G; Vergalli J; Mariani SA; Guerzoni C; Calabretta B J Cell Biochem; 2012 May; 113(5):1704-13. PubMed ID: 22212957 [TBL] [Abstract][Full Text] [Related]
2. Block of C/EBP alpha function by phosphorylation in acute myeloid leukemia with FLT3 activating mutations. Radomska HS; Bassères DS; Zheng R; Zhang P; Dayaram T; Yamamoto Y; Sternberg DW; Lokker N; Giese NA; Bohlander SK; Schnittger S; Delmotte MH; Davis RJ; Small D; Hiddemann W; Gilliland DG; Tenen DG J Exp Med; 2006 Feb; 203(2):371-81. PubMed ID: 16446383 [TBL] [Abstract][Full Text] [Related]
3. E6AP, an E3 ubiquitin ligase negatively regulates granulopoiesis by targeting transcription factor C/EBPα for ubiquitin-mediated proteasome degradation. Pal P; Lochab S; Kanaujiya JK; Kapoor I; Sanyal S; Behre G; Trivedi AK Cell Death Dis; 2013 Apr; 4(4):e590. PubMed ID: 23598402 [TBL] [Abstract][Full Text] [Related]
4. The biological effects of C/EBPalpha in K562 cells depend on the potency of the N-terminal regulatory region, not on specificity of the DNA binding domain. Ferrari-Amorotti G; Mariani SA; Novi C; Cattelani S; Pecorari L; Corradini F; Soliera AR; Manzotti G; Fragliasso V; Zhang Y; Martinez RV; Lam EW; Guerzoni C; Calabretta B J Biol Chem; 2010 Oct; 285(40):30837-50. PubMed ID: 20659895 [TBL] [Abstract][Full Text] [Related]
5. Identification of the C/EBPα C-terminal tail residues involved in the protein interaction with GABP and their potency in myeloid differentiation of K562 cells. Shimokawa T; Nunomura S; Fujisawa D; Ra C Biochim Biophys Acta; 2013 Nov; 1829(11):1207-17. PubMed ID: 24076158 [TBL] [Abstract][Full Text] [Related]
9. Transcription activation function of C/EBPalpha is required for induction of granulocytic differentiation. Keeshan K; Santilli G; Corradini F; Perrotti D; Calabretta B Blood; 2003 Aug; 102(4):1267-75. PubMed ID: 12702500 [TBL] [Abstract][Full Text] [Related]
10. Phosphorylation of C/EBPalpha inhibits granulopoiesis. Ross SE; Radomska HS; Wu B; Zhang P; Winnay JN; Bajnok L; Wright WS; Schaufele F; Tenen DG; MacDougald OA Mol Cell Biol; 2004 Jan; 24(2):675-86. PubMed ID: 14701740 [TBL] [Abstract][Full Text] [Related]
11. Transcriptional repression of c-Myb and GATA-2 is involved in the biologic effects of C/EBPalpha in p210BCR/ABL-expressing cells. Soliera AR; Lidonnici MR; Ferrari-Amorotti G; Prisco M; Zhang Y; Martinez RV; Donato NJ; Calabretta B Blood; 2008 Sep; 112(5):1942-50. PubMed ID: 18550858 [TBL] [Abstract][Full Text] [Related]
12. Expression of the transcriptional repressor Gfi-1 is regulated by C/EBP{alpha} and is involved in its proliferation and colony formation-inhibitory effects in p210BCR/ABL-expressing cells. Lidonnici MR; Audia A; Soliera AR; Prisco M; Ferrari-Amorotti G; Waldron T; Donato N; Zhang Y; Martinez RV; Holyoake TL; Calabretta B Cancer Res; 2010 Oct; 70(20):7949-59. PubMed ID: 20924107 [TBL] [Abstract][Full Text] [Related]
13. Ras signaling enhances the activity of C/EBP alpha to induce granulocytic differentiation by phosphorylation of serine 248. Behre G; Singh SM; Liu H; Bortolin LT; Christopeit M; Radomska HS; Rangatia J; Hiddemann W; Friedman AD; Tenen DG J Biol Chem; 2002 Jul; 277(29):26293-9. PubMed ID: 11978795 [TBL] [Abstract][Full Text] [Related]
14. Targeting CDK1 promotes FLT3-activated acute myeloid leukemia differentiation through C/EBPα. Radomska HS; Alberich-Jordà M; Will B; Gonzalez D; Delwel R; Tenen DG J Clin Invest; 2012 Aug; 122(8):2955-66. PubMed ID: 22797303 [TBL] [Abstract][Full Text] [Related]
15. Repression of transcriptional activity of C/EBPalpha by E2F-dimerization partner complexes. Zaragoza K; Bégay V; Schuetz A; Heinemann U; Leutz A Mol Cell Biol; 2010 May; 30(9):2293-304. PubMed ID: 20176812 [TBL] [Abstract][Full Text] [Related]
16. E3 ligase SCF Thacker G; Mishra M; Sharma A; Singh AK; Sanyal S; Trivedi AK Life Sci; 2020 Sep; 257():118041. PubMed ID: 32622945 [TBL] [Abstract][Full Text] [Related]
17. Ring finger protein 138 inhibits transcription factor C/EBPα protein turnover leading to differentiation arrest in acute myeloid leukemia. Singh AK; Upadhyay V; Sethi A; Chowdhury S; Mishra S; Verma SP; Bhatt MLB; Trivedi AK Biochem J; 2024 May; 481(10):653-666. PubMed ID: 38666590 [TBL] [Abstract][Full Text] [Related]
18. C/EBPalphap30, a myeloid leukemia oncoprotein, limits G-CSF receptor expression but not terminal granulopoiesis via site-selective inhibition of C/EBP DNA binding. Cleaves R; Wang QF; Friedman AD Oncogene; 2004 Jan; 23(3):716-25. PubMed ID: 14737106 [TBL] [Abstract][Full Text] [Related]
19. Regulation of granulocyte and monocyte differentiation by CCAAT/enhancer binding protein alpha. Friedman AD; Keefer JR; Kummalue T; Liu H; Wang QF; Cleaves R Blood Cells Mol Dis; 2003; 31(3):338-41. PubMed ID: 14636649 [TBL] [Abstract][Full Text] [Related]
20. Elevated PIN1 expression by C/EBPalpha-p30 blocks C/EBPalpha-induced granulocytic differentiation through c-Jun in AML. Pulikkan JA; Dengler V; Peer Zada AA; Kawasaki A; Geletu M; Pasalic Z; Bohlander SK; Ryo A; Tenen DG; Behre G Leukemia; 2010 May; 24(5):914-23. PubMed ID: 20376080 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]